COMMUNIQUÉS West-GlobeNewswire

Third Year in a Row, LifeLabs Named by Forbes as one of Canada's Best Employers for Diversity

15/07/2024 - 15:45

Toronto, July 15, 2024 (GLOBE NEWSWIRE) -- LifeLabs has once again been named one of Canada's Best Employers for Diversity by Forbes. This is the third consecutive year LifeLabs has received this recognition. Forbes and [...]

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

15/07/2024 - 15:31

HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]

IR-MED Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

15/07/2024 - 15:15

DiaSafe ™ , IR-MED’s second product , is being developed to provide safe, real-time optical readings of biomarkers to detect the early presence of diabetic foot ulcers with high accuracy Th e most common cause of [...]

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

15/07/2024 - 15:05

Live video webcast on Wednesday, July 17 th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]

SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update

15/07/2024 - 15:05

Five total abstracts presented at ASPN 2024 CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American [...]

Chromocell to Participate in the Virtual Investor Lunch Break Series

15/07/2024 - 15:00

Live webcast with Frank Knuettel II, Chief Executive Officer and Chief Financial Officer, on Thursday, July 18th at 12:00 PM ET FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“ [...]

Kane Biotech Announces Issuance of Restricted Share Units

15/07/2024 - 14:30

WINNIPEG, Manitoba, July 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 4,213,133 restricted share units of the Company (“ [...]

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

15/07/2024 - 14:30

ART26.12 seeks to address a critical need in painful neuropathies, including chemotherapy-induced peripheral neuropathy for which there is no FDA-approved treatment Phase 1 trial results expected in the first half of [...]

Safety Shot Partners with KeHE Distributors to Expand Nationwide Access

15/07/2024 - 14:30

The Partnership Will Greatly Expand Market Reach for Safety Shot to Meet Increased Demand and a Broader Consumer Audience JUPITER, FL, July 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc . (Nasdaq: SHOT) (the “Company), [...]

Sienna Announces July Dividend

15/07/2024 - 14:30

MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

15/07/2024 - 14:05

SANTA ANA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

15/07/2024 - 14:00

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN, South Korea and WALTHAM, Mass., July 15, 2024 ( [...]

Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop

15/07/2024 - 14:00

– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 [...]

Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts

15/07/2024 - 14:00

The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading [...]

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications

15/07/2024 - 14:00

HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applications for crucial [...]

Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024

15/07/2024 - 14:00

PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2024 financial results on Monday, [...]

Spectral AI Continues Support of Naked Short Selling Inquiry

15/07/2024 - 14:00

DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

15/07/2024 - 22:30

MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

15/07/2024 - 22:09

SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report [...]